ODTC's logo.
Ticker Symbol: ODTC

Odonate Therapeutics Inc

Exchange: OTC MARKETS Country: US Currency: USD Asset Type: Common Stock CIK:0001717452

Company Profile

Odonate Therapeutics, Inc. is a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. Odonate’s initial focus is on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class of drugs known as taxanes, which are widely used in the treatment of cancer. Odonate’s goal for tesetaxel is to develop an effective chemotherapy choice for patients that provides quality-of-life advantages over current alternatives.

Sector: Manufacturing
Industry: Medicinal and Botanical Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 4747 Executive Dr
CEO: N/A
Tags: N/A

Pricing

Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change: - ( 0.00%)
Days Range: $1.50 - $1.80
Beta: -
52wk. High: $4,840.00
52wk. Low: $3,000.00
Ytd. Change -14.29%
50 Day Moving Average: $3,000.00
200 Day Moving Average: $3,377.08
Shares Outstanding: 28529414

Valuation

Market Cap: 4.3B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A